Op-Ed: Medicare proposes a barrier to an innovative Alzheimer's diagnostic tool
By George Vradenburg, Howard Fillit, MD and Michael W.Weiner, MD
Earlier this month, the Centers for Medicare and Medicaid Services (CMS) issued a draft Decision Memorandum to deny Medicare reimbursements to patients using an innovative FDA-approved Alzheimer's diagnostic technology designed to help physicians identify whether patients with signs of cognitive impairment may have Alzheimer's or are in fact suffering from another form of dementia. This information is vital to patients, their providers, choices regarding their treatment and their ultimate health outcomes.
Read the full piece in today's edition of The Hill